Loading clinical trials...
Loading clinical trials...
A 12-Week Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Assess the Efficacy of Oral Fosamprenavir for Laryngopharyngeal Reflux
Conditions
Interventions
Fosamprenavir Calcium
Placebo
Locations
1
United States
Froedtert Hospital
Milwaukee, Wisconsin, United States
Start Date
April 1, 2026
Primary Completion Date
June 1, 2027
Completion Date
October 1, 2027
Last Updated
February 9, 2026
NCT04827355
NCT05296655
NCT01317472
NCT00864396
NCT00369265
Lead Sponsor
Medical College of Wisconsin
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions